![Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7020e2_EffectivenessPfizerModernaHCP_IMAGE_14May21_1200x675.jpg)
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR
High-Resolution Melting-Curve Analysis of obg Gene to Differentiate the Temperature-Sensitive Mycoplasma synoviae Vaccine Strain MS-H from Non- Temperature-Sensitive Strains | PLOS ONE
![Full article: Ensuring quality and integrity of vaccines throughout the cold chain: the role of temperature monitoring Full article: Ensuring quality and integrity of vaccines throughout the cold chain: the role of temperature monitoring](https://www.tandfonline.com/cms/asset/c3283ca4-eebe-4749-a029-949d51f3222e/ierv_a_2061462_f0002_oc.jpg)
Full article: Ensuring quality and integrity of vaccines throughout the cold chain: the role of temperature monitoring
![Novel technology for storage and distribution of live vaccines and other biological medicines at ambient temperature | Science Advances Novel technology for storage and distribution of live vaccines and other biological medicines at ambient temperature | Science Advances](https://www.science.org/cms/asset/6ee08845-ad27-4eca-95da-72e2e2d0e29b/aau4819-f1.gif)
Novel technology for storage and distribution of live vaccines and other biological medicines at ambient temperature | Science Advances
![COVID-19 vaccine development: milestones, lessons and prospects | Signal Transduction and Targeted Therapy COVID-19 vaccine development: milestones, lessons and prospects | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-00996-y/MediaObjects/41392_2022_996_Fig1_HTML.png)
COVID-19 vaccine development: milestones, lessons and prospects | Signal Transduction and Targeted Therapy
![Anoo Bhuyan on X: "How sensitive are vaccines already in India's child immunisation prog? -Most vaccines need to be at 2 to 8°C! -Polio & rotavirus vac needs to be at -15 Anoo Bhuyan on X: "How sensitive are vaccines already in India's child immunisation prog? -Most vaccines need to be at 2 to 8°C! -Polio & rotavirus vac needs to be at -15](https://pbs.twimg.com/media/Ej4pRDaVkAQEyhM.png)
Anoo Bhuyan on X: "How sensitive are vaccines already in India's child immunisation prog? -Most vaccines need to be at 2 to 8°C! -Polio & rotavirus vac needs to be at -15
![Vaccines | Free Full-Text | Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine Vaccines | Free Full-Text | Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine](https://pub.mdpi-res.com/vaccines/vaccines-10-00086/article_deploy/html/images/vaccines-10-00086-g001.png?1641782942)